Feed INSP
IN

Inspire Medical Systems INSP · NYSE

$63.97 -3.85% (-$2.56)

Summary

69 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 31% a year over the last 3 years.
  • It holds more cash than debt: $190.8M against $28.6M.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 USD of revenue, 11 USD is left as net profit.

What to watch

  • Analysts expect revenue to fall by 6.2% this fiscal year.
  • It earns only 6.0 USD a year on every 100 USD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $63.97
P/E today 18.4
Medical - Devices industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 18.4 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 51% a year over 5 years. Over the last 3 years it grew by 31% a year. For the next fiscal year analysts expect revenue to fall by 6.2%.

Growth in detail

Does it make money?

Reasonably

Where 100 USD of revenue goes

Net profit, industry median (Medical - Devices) 6.5 USD

Out of every 100 USD of revenue, 11 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $64.67 is 1.1% above today's price. 41% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Operating Segment brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy